ArticleMicrobial cell factories2026
Biocatalytic ulvan degradation by Pseudoalteromonas marina: exploring a marine polysaccharide bioconversion system.
Article in Microbial cell factories, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Ulvan depolymerization by marine bacteria is a specialized metabolic capability with significant implications for marine carbon cycling and biotechnological applications. While ulvan degradation systems have been extensively characterized in Bacteroidota, their occurrence and mechanisms in Pseudomonadota remain poorly understood. This study proposed a putative ulvan utilization system in the marine bacterium Pseudoalteromonas marina PUA1001, representing a notable metabolic expansion beyond the typical Pseudomonadota repertoire. Comparative genomic analysis with the closely related strain P. marina mano4 (97.5% OrthoANI) revealed a complete absence of the ulvan utilization locus in mano4, suggesting a possible role and strain-level metabolic specialization. The model PUA1001 ulvan utilization locus comprises three polysaccharide lyases (PL24, PL25, PL40), seven glycoside hydrolases, including previously unreported GH106 and GH115 families, two sulfatases, and seven accessory genes, predicted to enable stepwise depolymerization of ulvan to monosaccharides. Biochemical characterization of the three recombinantly expressed ulvan lyases revealed optimal activities at 35-50 °C and pH 8.0, with significant Mn²⁺-dependent activity enhancement (1.25 - 2 fold). Molecular docking analysis of PmUL24 and PmUL25 confirmed conservation of the His/Tyr-dependent β-elimination mechanism. This polysaccharide utilization system may contribute to the ecological success of Pseudoalteromonas species in ulvan-rich marine environments, highlighting adaptive flexibility and strain-specific potential for exploiting distinct polysaccharide niches within marine ecosystems.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.